-The Economic Times NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe. "At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia," a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET. The Australian...
More »SEARCH RESULT
A home-grown epidemic
-The Hindu That predators continue to enjoy impunity for crimes committed against women is now common knowledge. But less known is the fact that the worst perpetrators are often those most intimately known to women, or that the latter are vulnerable in consequence to life-long health-related risks. These frightening revelations are contained in a recent World Health Organisation report, issued in collaboration with the London School of Hygiene and Tropical...
More »More than cereals
-The Business Standard UN report shows holes in govt's food security proposal The United Nations' Food and Agriculture Organisation (FAO) has worked out the cost of malnutrition to the world economy: about five per cent of its annual gross domestic product, or $3.5 trillion, in terms of foregone production and health expenditure. Even more important is the FAO's assessment of potential gains from investment in enhancing the nutritional standards of the population....
More »Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar
-The Hindu Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses. One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India's programme, which is of intermittent schedule. "WHO currently recommends governments to consider...
More »Who Manufactures Dirty Medicines?-Amit Sengupta
-Newsclick.in A few weeks back Fortune magazine and CNN carried a long online blog titled ‘Dirty Medicine' by Dinesh Thakur, a former employ of Ranbaxy, where he recounts how he came across several procedural and other lapses in the company's manufacturing facilities. Since then the Fortune blog has become one of the most widely circulated and commented upon business stories in the world. The story received attention as it came in the...
More »